Yinuorui has been granted a new invention patent.

Recently, YinoRi received an invention patent certificate for “A Method for Separating and Purifying the Active Pharmaceutical Ingredient Sulodexide from Heparin By-Products,” with patent number ZL201910036378X. The patent was filed on January 15, 2019, and was granted and announced on April 27, 2021.

Obtaining this national patent certificate not only helps to improve the intellectual property protection system and leverage our company’s advantages in independent intellectual property rights, but also enhances our company’s core competitiveness. Building on our existing patents, our company will vigorously deepen product reforms, place particular emphasis on strengthening the protection and utilization of intellectual property rights, accelerate product innovation, and promote the commercialization of research findings.